Evidence map›Paper›PMID 41673388›Full record

ArticleNature communications2026

Mechanochemical engineering of chiroptical properties in indium-based chiral metal halides by grinding.

Junhong Wu, Hao Li, Jialu Wang, Xiaorui Yang, Tianyong Zhang, Bin Li, Shuang Jiang

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junhong WuSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, P. R. China.
Hao LiSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, P. R. China.
Jialu WangSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, P. R. China.
Xiaorui YangSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, P. R. China.
Tianyong ZhangSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, P. R. China.
Bin LiSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, P. R. China.
Shuang JiangSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, P. R. China. shuangjiang@tju.edu.cn.ORCID http://orcid.org/0000-0003-2996-5562

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circularly polarized luminescence is crucial for optoelectronics, bioimaging, and three-dimensional display, yet most of current materials suffer from complex synthesis and limited tunability. Herein, we show the regulation of chiroptical properties in metal halides through mechanochemical engineering. Specifically, phosphorescent indium-based chiral metal halides exhibit blue circularly polarized luminescence, along with antimony-doped indium-based metal halides emit orange circularly polarized luminescence. A grinding strategy using bromide salts like potassium bromide induces bright yellow fluorescence and enables versatile circularly polarized luminescence modulation. When antimony-doped indium-based metal halides are ground with five different bromide salts, it exhibits intriguing and tunable properties: (i) enhanced circularly polarized luminescence, with a luminescence dissymmetry factor value up to 10⁻²; (ii) inversion of the circularly polarized luminescence signal; (iii) generation of near-infrared circularly polarized luminescence with a substantial Stokes shift of 370 nm; and most notably, (iv) a 29.71-fold improvement in second-harmonic generation efficiency. This approach also realizes applications in circularly polarized light-emitting diodes.

Identifiers

PMID41673388
PMCPMC13002971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.